Concepedia

Chunrong Yu

CY

Statistics

Publications

40

Citations

3.6K

H-Index

35

Active since

2001

Affiliations

Virginia Commonwealth University Medical Center(Current)

Roswell Park Comprehensive Cancer Center

Mayo Clinic in Arizona

Wuhan University

Chunrong Yu is an author at Virginia Commonwealth University Medical Center specializing in oncology, pharmacology, and molecular oncology.

Publications per year

2001–2021

40

Publications

40

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006

Chunrong Yu, Laura M. Bruzek, Xue Meng et al. · Oncogene · 2005 · 274 citations

Life Sciences, Cell Biology, Oncology +15

The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571

Chunrong Yu, Mohamed Rahmani, Daniel H. Conrad et al. · Blood · 2003 · 261 citations

Life Sciences, Molecular Biology, Pharmacology +15

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†

Jinping Lai, Dalbir S. Sandhu, Chunrong Yu et al. · Hepatology · 2008 · 206 citations · Full text

Medicine, Molecular Biology, Oncology +17

Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

Chunrong Yu, Geoffrey W. Krystal, Lyuba Varticovksi et al. · PubMed · 2002 · 192 citations

Life Sciences, Oncology, Pharmacology +17

The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib

Chunrong Yu, Mohamed Rahmani, Paul Dent et al. · Experimental Cell Research · 2004 · 150 citations

Life Sciences, Cell Biology, Oncology +17

1–5 of 40